Maziar Mike Doustdar

Maziar Mike Doustdar

business executive Denmark

Maziar Mike Doustdar is a prominent Austrian-Iranian business executive, currently serving as the head of international operations for Novo Nordisk, a leading pharmaceutical company specializing in obesity treatments. Based in Zurich, Doustdar oversees a substantial revenue stream for the company, which has become a market leader in innovative weight-loss injections. His career at Novo Nordisk began at the age of 22, and through years of dedication and various roles, he ascended to his current position, demonstrating a remarkable ability to navigate the complexities of the pharmaceutical industry. Known for his approachable leadership style, Doustdar emphasizes the importance of humility in a rapidly growing business segment.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
77,873
Power
3,348$
Sentiment
5.84
Countries Mentioned
Country Mentions Sentiment Dominance + Persistence x Population = Reach x GDP (millions) = Power
Denmark 2 9.00 0.13% +0% 5,792,202 7,702 $350,000 465$
United Kingdom 1 6.00 0.03% +0% 67,886,011 23,753 $2,700,000 945$
Italy 1 5.00 0.06% +0% 60,461,826 34,569 $2,000,000 1,144$
Sweden 1 7.00 0.06% +0% 10,099,265 5,788 $530,000 304$
Switzerland 1 7.00 0.07% +0% 8,654,622 6,061 $700,000 490$
Totals 6 152,893,926 77,873 $6,280,000 3,348$
Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Denmark Denmark: Maziar Mike Doustdar has dedicated his entire working life to Novo Nordisk. 9

Politiken: Valget af Mike Doustdar sender et signal, der især handler om penge

Sweden Sweden: Maziar Mike Doustdar has been appointed as the new CEO of Novo Nordisk. 7

Dagens Nyheter: Novo Nordisk rasar på börsen efter sänkta prognoser

Denmark Denmark: Maziar Mike Doustdar has been appointed as the new CEO of Novo Nordisk. 9

Politiken: Novo Nordisk udpeger ny topchef midt i aktiestyrtdyk

Switzerland Switzerland: Maziar Mike Doustdar is the head of international business for the Danish pharmaceutical group Novo Nordisk. 8

Neue Zürcher Zeitung: keine Engpässe mehr bei Abnehmspritzen